KRAS G12C/D/V/G13D program (AnHorn Medicines)

N/A

Report date: 2025/08/13 14:18:14
NME

Base Information

Drug NameKRAS G12C/D/V/G13D program (AnHorn Medicines)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G12C modulatorsKRAS G12D modulatorsKRAS G12V modulators +[4] 
TargetsKRAS G12CKRAS G12DKRAS G12V +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnHorn Medicines Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnHorn Medicines Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A